SG11201901081XA - Process for the preparation of highly concentrated liquid formulations containing biomolecules - Google Patents
Process for the preparation of highly concentrated liquid formulations containing biomoleculesInfo
- Publication number
- SG11201901081XA SG11201901081XA SG11201901081XA SG11201901081XA SG11201901081XA SG 11201901081X A SG11201901081X A SG 11201901081XA SG 11201901081X A SG11201901081X A SG 11201901081XA SG 11201901081X A SG11201901081X A SG 11201901081XA SG 11201901081X A SG11201901081X A SG 11201901081XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rhein
- binger
- ingelheim
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000012669 liquid formulation Substances 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 238000011026 diafiltration Methods 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000000108 ultra-filtration Methods 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16184502 | 2016-08-17 | ||
| PCT/EP2017/070423 WO2018033482A1 (en) | 2016-08-17 | 2017-08-11 | Process for the preparation of highly concentrated liquid formulations containing biomolecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201901081XA true SG11201901081XA (en) | 2019-03-28 |
Family
ID=56740111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901081XA SG11201901081XA (en) | 2016-08-17 | 2017-08-11 | Process for the preparation of highly concentrated liquid formulations containing biomolecules |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11572385B2 (de) |
| EP (1) | EP3500588A1 (de) |
| JP (3) | JP7114567B2 (de) |
| KR (1) | KR102457855B1 (de) |
| CN (2) | CN110198952B9 (de) |
| AU (2) | AU2017313268C1 (de) |
| CA (1) | CA3031860A1 (de) |
| SG (1) | SG11201901081XA (de) |
| WO (1) | WO2018033482A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11957746B2 (en) | 2018-03-26 | 2024-04-16 | Boehringer Ingelheim Animal Health USA Inc. | Method of producing an immunogenic composition |
| JP7465215B2 (ja) * | 2018-04-12 | 2024-04-10 | アムジェン インコーポレイテッド | 安定なタンパク質組成物を製造する方法 |
| MA52570A (fr) | 2018-05-10 | 2021-03-17 | Regeneron Pharma | Formulations contenant des protéines de fusion du récepteur vegf à haute concentration |
| CN111096456A (zh) * | 2020-02-14 | 2020-05-05 | 江西师范大学 | 一种荷叶中抑制晚期糖基化产物形成活性组分的制备方法 |
| KR20240050373A (ko) | 2021-09-02 | 2024-04-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 미래의 색값 또는 대응하는 특성을 결정하는 방법 및 이를 위한 장치 |
| WO2024008256A1 (en) * | 2022-07-05 | 2024-01-11 | Lihme Protein Solutions | Improved apparatus for compound separation |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ199058A (en) * | 1980-12-05 | 1985-04-30 | Schreiber Foods Inc | Producing cheese or a cheese base containing casein and whey proteins |
| SE500110C2 (sv) | 1989-06-27 | 1994-04-18 | Kabi Pharmacia Ab | Sätt att rena ett protein från därtill bundna flervärda metalljoner |
| US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
| US5564414A (en) | 1994-05-26 | 1996-10-15 | Walker; William F. | Pressurized and metered medication dose counter on removable sleeve |
| US6312755B1 (en) * | 1999-07-16 | 2001-11-06 | Ampc | Whey treatment process for achieving high concentration of α-lactalbumin |
| US6693173B2 (en) | 2000-12-26 | 2004-02-17 | Alpha Therapeutic Corporation | Method to remove citrate and aluminum from proteins |
| GB0113179D0 (en) * | 2001-05-31 | 2001-07-25 | Novartis Ag | Organic compounds |
| US6712963B2 (en) * | 2002-06-14 | 2004-03-30 | Scilog, Llc | Single-use manifold for automated, aseptic transfer of solutions in bioprocessing applications |
| US7241874B2 (en) * | 2002-06-26 | 2007-07-10 | Zimmer Ortho Biologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
| PT1658872E (pt) | 2002-07-31 | 2011-05-12 | Chiesi Farma Spa | Inalador de p? |
| EP1596667B1 (de) | 2002-11-01 | 2009-01-21 | Bayer HealthCare LLC | Verfahren zur Konzentration von Proteinen |
| EP1713904B1 (de) | 2004-01-30 | 2016-06-29 | Shire Pharmaceuticals Ireland Limited | Herstellung und reinigung rekombinanter arylsulfatase a |
| US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| AU2005229674B2 (en) * | 2004-11-18 | 2010-11-04 | Kedrion Melville Inc. | Low concentration solvent/detergent process of immuneglobulin with pre-treatment |
| AU2006284173A1 (en) | 2005-08-24 | 2007-03-01 | Boehringer Ingelheim International Gmbh | Atomiser comprising a counter and an end of operation lock |
| US20090098202A1 (en) * | 2006-02-10 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Extended Release Formulation |
| US20070246406A1 (en) * | 2006-03-31 | 2007-10-25 | Dibel Kevin R | Tangential flow filtration apparatuses, systems, and processes for the separation of compounds |
| ES2294976B1 (es) | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion". |
| US8420081B2 (en) * | 2007-11-30 | 2013-04-16 | Abbvie, Inc. | Antibody formulations and methods of making same |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| US10080853B2 (en) | 2011-05-23 | 2018-09-25 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012161685A1 (en) | 2011-05-23 | 2012-11-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| JP2013043865A (ja) * | 2011-08-25 | 2013-03-04 | Osaka Prefecture Univ | 血中脂質降下剤及び高分子アディポネクチン産生促進剤 |
| GB201115874D0 (en) | 2011-09-14 | 2011-10-26 | Astrazeneca Ab | Inhaler |
| GB201122430D0 (en) | 2011-12-23 | 2012-02-08 | Xstalbio Ltd | Reconstitution method for high concentration dry protein formulation |
| CA2887684A1 (en) * | 2012-10-30 | 2014-05-08 | Peter Becker | Purification of polypeptides using dual stage tangential-flow ultrafiltration |
-
2017
- 2017-08-11 KR KR1020197007702A patent/KR102457855B1/ko active IP Right Review Request
- 2017-08-11 WO PCT/EP2017/070423 patent/WO2018033482A1/en unknown
- 2017-08-11 AU AU2017313268A patent/AU2017313268C1/en active Active
- 2017-08-11 EP EP17754327.9A patent/EP3500588A1/de active Pending
- 2017-08-11 CN CN201780064105.5A patent/CN110198952B9/zh active Active
- 2017-08-11 CN CN202410148906.1A patent/CN118085011A/zh active Pending
- 2017-08-11 US US16/325,763 patent/US11572385B2/en active Active
- 2017-08-11 SG SG11201901081XA patent/SG11201901081XA/en unknown
- 2017-08-11 CA CA3031860A patent/CA3031860A1/en active Pending
- 2017-08-11 JP JP2019508243A patent/JP7114567B2/ja active Active
-
2022
- 2022-06-07 JP JP2022092326A patent/JP2022120016A/ja active Pending
-
2024
- 2024-04-04 JP JP2024060940A patent/JP2024081786A/ja active Pending
- 2024-04-10 AU AU2024202299A patent/AU2024202299A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022120016A (ja) | 2022-08-17 |
| CN110198952B9 (zh) | 2024-05-28 |
| WO2018033482A1 (en) | 2018-02-22 |
| KR102457855B1 (ko) | 2022-10-25 |
| CN110198952B (zh) | 2024-03-01 |
| AU2017313268A1 (en) | 2019-02-07 |
| JP7114567B2 (ja) | 2022-08-08 |
| AU2017313268C1 (en) | 2024-10-10 |
| KR20190038921A (ko) | 2019-04-09 |
| US11572385B2 (en) | 2023-02-07 |
| JP2019535641A (ja) | 2019-12-12 |
| CN110198952A (zh) | 2019-09-03 |
| CA3031860A1 (en) | 2018-02-22 |
| US20190309016A1 (en) | 2019-10-10 |
| CN118085011A (zh) | 2024-05-28 |
| EP3500588A1 (de) | 2019-06-26 |
| JP2024081786A (ja) | 2024-06-18 |
| AU2024202299A1 (en) | 2024-05-02 |
| AU2017313268B2 (en) | 2024-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201901081XA (en) | Process for the preparation of highly concentrated liquid formulations containing biomolecules | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201901206SA (en) | Trimer stabilizing hiv envelope protein mutations | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
| SG11201908280SA (en) | "chimeric molecules and uses thereof" | |
| SG11201903454VA (en) | Immunologically discernible cell surface variants for use in cell therapy | |
| SG11201900799XA (en) | Pyridopyrimdinone cdk2/4/6 inhibitors | |
| SG11201811807XA (en) | Dairy product and process | |
| SG11201810048VA (en) | Tri-segmented pichinde viruses as vaccine vectors | |
| SG11201811363YA (en) | Anti-zika virus antibodies and methods of use | |
| SG11201810429UA (en) | Anti-cd19 antibody formulations | |
| SG11201803593QA (en) | Engineered nucleic-acid targeting nucleic acids | |
| SG11201811446SA (en) | Process for recovering viral products using functionalised chromatography media | |
| SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
| SG11201901684XA (en) | Anti-dengue virus antibodies, polypeptides containing variant fc regions, and methods of use | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201407988UA (en) | Process for improved opioid synthesis | |
| SG11201404836QA (en) | Long-acting coagulation factors and methods of producing same | |
| SG11201900618WA (en) | Permanently polarized hydroxyapatite, a process for its manufacture and uses thereof | |
| SG11201810078PA (en) | Stabilized pre-fusion rsv f proteins |